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Abstract
Background: Dilated cardiomyopathy is a myocardial disease occurring in humans and domestic
animals and is characterized by dilatation of the left ventricle, reduced systolic function and
increased sphericity of the left ventricle. Dilated cardiomyopathy has been observed in several,
mostly large and giant, dog breeds, such as the Dobermann and the Great Dane. A number of genes
have been identified, which are associated with dilated cardiomyopathy in the human, mouse and
hamster. These genes mainly encode structural proteins of the cardiac myocyte.
Results: We present the annotation of, and marker development for, 14 of these genes of the dog
genome, i.e. α-cardiac actin, caveolin 1, cysteine-rich protein 3, desmin, lamin A/C, LIM-domain
binding factor 3, myosin heavy polypeptide 7, phospholamban, sarcoglycan δ, titin cap, α-
tropomyosin, troponin I, troponin T and vinculin. A total of 33 Single Nucleotide Polymorphisms
were identified for these canine genes and 11 polymorphic microsatellite repeats were developed.
Conclusion:  The presented polymorphisms provide a tool to investigate the role of the
corresponding genes in canine Dilated Cardiomyopathy by linkage analysis or association studies.
Background
Dilated cardiomyopathy (DCM) is a myocardial disease
characterized by dilatation of the left ventricle, reduced
systolic function and increased sphericity of the left ven-
tricle. This disease has been described in different species
and multiple genes have been found in the human [1],
mouse [2] and hamster [3] causing DCM. These genes
mainly encode cyto-skeletal components of the cardiac
myocytes and can be divided into sarcomeric and extra-
sarcomeric proteins. The identified sarcomeric proteins
involved in DCM include α-cardiac actin, encoded by
ACTC  [4], cysteine-rich protein 3 (CSRP3) [5], LIM-
domain binding factor 3 (LDB3, also known as Cypher or
ZASP) [6], myosin heavy polypeptide 7 (MYH7) [7], titin
cap (TCAP) [8], α-tropomyosin (TPM1), troponin I
(TNNI3) [9], troponin T (TNNT2) [7], titin (TTN) [10]
and vinculin (VCL) [11]. The extra-sarcomeric proteins
implicated in DCM are encoded by the genes including
caveolin 1 (CAV1) [2], desmin (DES) [12], lamin A/C
(LMNA) [13], phospholamban (PLN) [14] and sarcogly-
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can δ (SGCD) [3]. The genes encoding all of the above
proteins are located on the autosomal chromosomes. X-
linked genes implicated in DCM include dystrophin
(DYS) [15] and tafazzin (TAZ) [16]. In addition, mito-
chondrial dysfunction and mitochondrial DNA (mtDNA)
mutations have been associated with maternally inherited
DCM [17]. Furthermore, DCM has also been described
with arrhythmias, with mutations in genes encoding
sodium [18] and potassium channels [19].
DCM has been described in many different breeds of
mostly giant and large dogs, including the Dobermann
[20], Great Dane [21], Newfoundland [22] and Irish
Wolfhound [23]. Clinical variation exists in the presenta-
tion and progression of DCM between different dog
breeds and breed specific variation has also been found in
histological findings in DCM-affected hearts tissue [24].
Since clinical DCM may be a late onset disease, following
a long pre-symptomatic course, dogs are often used for
breeding before the disease becomes apparent [25]. So far,
no causative mutation has been discovered in canine
DCM. The phenotype of the adult onset forms of canine
DCM in most breeds is consistent with a defect in compo-
nents of the cytoskeleton.
Of the 14 autosomal DCM candidate genes for the dog,
ACTC, CAV1, CSRP3, DES, LDB3, LMNA, MYH7, PLN,
SGCD, TCAP, TNNI3, TNNT2, TPM1 and VCL, genomic
information and/or polymorphic markers were already
available for ACTC [26,27], DES [28], PLN [29], SGCD
[30] and TPM1 [31]. In this article, we describe a complete
set of polymorphic markers for these 14 candidate genes
for canine DCM. The markers, both microsatellites and
Single Nucleotide Polymorphisms (SNPs), provide a use-
ful tool to perform linkage and association studies
between each of these genes and DCM in the different dog
breeds. Furthermore, we present the annotation of 14 can-
didate genes in the canine genome, which will facilitate
mutation screening of these genes.
Genomic Annotation
The 14 canine DCM candidate genes were identified on
the canine genome by means of a BLAST analysis [32],
using available canine and human DNA sequences as a
query (Table 1). The exons were identified based on the
corresponding human exon sequence (retrieved from
[33], Table 1). Each gene was found to be covered by 1 to
5 contigs of the Canis familiaris genome build 1.1. (Addi-
tional file 1 and Table 1). CAV1 was covered by 2 neigh-
bouring contigs and the 3 coding exons matched the
human ones. Exon 1 of the dog seemed to have an extra
nucleotide (T, position 336 of [Genbank:
AAEX01048547]) compared to human exon 1 of CAV1.
However, this nucleotide was not present in the single
trace file of the Canis familiaris Trace Archive [34] covering
this sequence. Canine DES had 1 amino acid less than the
human protein. The canine LDB3 protein is 67 amino
acids shorter than human LDB3. Canine LMNA had 1
amino acid extra compared to the human protein. Exon
24 of canine MYH7 seemed to have 1 bp extra (G, bp
7,902 of [Genbank: AAEX01041100]), however, this
nucleotide was not present in any of 11 Canis familiaris
trace sequences covering this position. Without this extra
nucleotide, canine exon 24 matched the human exon.
Canine TNNI3 had 1 amino acid extra compared to the
human protein. For TNNT2, coding exons 1, 15 and 16
could not be recognized in canine genomic contigs.
TNNT2 exon 6 showed 1 extra bp compared to human (G,
bp 5622 of [Genbank: AAEX01013360]), however, this
nucleotide was not found in the 2 traces covering this
DNA sequence. Without this additional bp, exon 6
matched the corresponding human exon exactly in length.
Exon 12 had 1 codon less than the human gene. Exon 13
was located at the end of genomic contig [Genbank:
AAEX01013360] and although its terminal 2 putative bp
were not included in this contig, exon 12 seemed to match
the human exon. For the remaining candidate genes,
ACTC, CSRP3, PLN, SGCD, TCAP, TPM1 and VCL, the
annotated canine exons matched the corresponding
human exons exactly. We could not identify non-coding
exons. Apparently, the conservation of these exons is too
low for identification purposes. Complementary DNA
sequencing is necessary to identify these non-coding
exons. All of the predicted introns of the 14 candidate
genes started and ended with the canonical GT and AG
dinucleotides, respectively [35]. Even though a high qual-
ity DNA sequence of the canine genome has recently
become available, it has not yet been fully annotated.
The conservation of the coding region of each gene was
assessed by BLAST comparison of the cDNA and derived
amino acid sequences with those of human (at the web-
site of NCBI [36], BLASTN and TBLASTX analysis, respec-
tively). The percentages of identity at the nucleotide level
varied between 88 and 95% (Table 1). At the amino acid
level, the percentages of identity varied in general between
90–100%, except for the canine LDB3 protein, that was
79% identical to the human protein. The canine ACTC
protein appeared to be identical to the human protein. In
LDB3, a relatively low percentage of identity was found
between the canine and human gene, both at the cDNA
and the protein level. This was caused by the large
(inframe) loss of part of exons (i.e. 4, 7, 8 and 9) com-
pared to the human gene: the canine gene had 660
codons, the human gene had 734 codons.
The chromosomal position of the 14 canine candidate
genes can be found in Table 1.BMC Veterinary Research 2007, 3:28 http://www.biomedcentral.com/1746-6148/3/28
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When analysing the location of the genes in the dog
genome (Table 1), using the canine-human comparative
map of Guyon et al. [37], each was found to be syntenic
to the human location.
Polymorphisms
Single Nucleotide Polymorphism detection
We used denaturing high-performance liquid chromatog-
raphy (DHPLC) analysis for the detection of SNPs in
amplified genomic canine DNA fragments. Polymor-
phisms were assessed in DNA from Newfoundland dogs.
For each gene, several DNA fragments of approximately
500 bp were selected based on melting profile (analyzed
with WAVEMAKER™ software from Transgenomic) with a
maximum of 2 melting temperatures covering each prod-
uct. The melting behaviour of a fragment depends on the
fragment's DNA sequence. Primers were designed using
Primer3 [38] and annealing temperatures of the PCRs
were optimized (Table 2). Touchdown PCR amplification
of these fragments was performed with DNA of New-
foundland dogs (n = 16; 8 unrelated founders of a pedi-
gree of Newfoundland dogs and 8 family members),
using HotStartTaq DNA Polymerase (Qiagen). The Touch-
down (TD) PCR program consisted of a denaturing step of
5 min at 95°C, followed by 14 cycles of 95°C 30 sec, Ta
+7°C 30 sec, 72°C 20 sec, with a Ta decrease of 0.5°C/
cycle, followed by 25 cycles of 30 sec at 94°C, 30 sec at
Ta°C, 30 sec at 72°C, followed by a final extension at
72°C for 2 min (Ta in Table 2). Subsequently, a heterodu-
plex formation step was carried out to allow formation of
hetero- and homo-duplex products; the PCR products
were heated 5 min at 95°C, after which the temperature
was decreased gradually (38 cycles of 1 min, temperature
decreasing 1.5°C/cycle), followed by a final step of 5 min
at 10°C. Mutation analysis of the PCR products, based on
the presence of heteroduplexes, followed on a WAVE
instrument (WAVE Nucleic Acid Fragment Analysis Sys-
tem, Transgenomic). Multiple WAVE patterns of a single
PCR fragment in different dogs pointed at existence of
both homoduplexes and heteroduplexes and, therefore,
indicated potential presence of SNPs in the fragment. In
that case, the PCR fragment (of at least of 2 dogs per
WAVE pattern) was cleaned (Shrimp Alkaline Phos-
phatase/ExoI) and the DNA sequence was obtained to
determine the identity of the SNPs, by a commercial com-
pany (Lark Technologies™, UK).
Twenty-eight SNPs were discovered by WAVE analysis
(Table 2). No indication of the presence of a SNP was
found in WAVE fragments of LMNA, MYH7 and TNNI3
(3, 5 and 3 fragments analyzed, respectively). One new
SNP, TCAP SNP 29,957 T/C in genomic contig [Genbank:
AAEX01022011], was found when we resequenced a
TCAP fragment in a group of Newfoundland dogs. WAVE
analysis of this fragment had not indicated presence of a
potential SNP – although the obtained DNA sequences
Table 1: Assignment, genomic location and the degree of sequence conservation compared to human of the canine DCM candidate 
genes.
Gene Annotation of canine gene CFA Similarity 
to human 4 
Identification 
sequence 1
ENST 00000..2 AAEX010... 3 Dog prot. (a.a.)
ACTC AF203019 (C), 290378 13478 377 30 100% AAB59619
AF203020 (C)
CAV1 U47060 (C) 341049 48546, 48547 178 14 96% NP_001744
CSRP3 BC024010 (H) 265968 17412 194 21 99% AAH24010
DES BK005142 (C) 273074 55032 469 37 97% NP_001918
LDB3 NM_007078 (H) 361816 16582, 16583(5), 16584 660 4 79% AB014513
LMNA AF427092 (C) 310777 12733, 12734 665 7 98% CAI15522
MYH7 NM_000257 (H) 355349 41099, 41100 1935 8 98% NP_000248
PLN Y00399 (C) 357525 14037 52 1 96% CAI21610
SGCD NM_000337 (H) 303006 16848, 16849(5), 16850(5), 16851, 16852 289 4 98% NP_000328
TCAP NM_003673 (H) 309889 22011 167 9 90% CAA09479
TNNI3 AF506750 (C) 344887 53923 211 1 95% CAG46782
TNNT2
(ex 2–14)
NM_000364 (H) 367317 13359, 13360 254 7 90% NP_000355
TPM1 NM_000366 (H) 288398 08742 284 30 99% AAH07433
VCL NM_003373 (H) 211998 16404 1134 4 99% NP_054706
1 Sequence used to identify the canine gene in the dog genome, Genbank accession numbers; C = canine sequence, H = human sequence; 2 
Transcript ID numbers of human annotation [33] used to annotate the canine gene; 3 canine genomic contig in which the gene's coding exons were 
identified; 4 the percentage identity of each canine protein compared to the human protein (Genbank accession number is listed); 5 canine genomic 
contig containing only intronic sequence.BMC Veterinary Research 2007, 3:28 http://www.biomedcentral.com/1746-6148/3/28
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Table 2: Single Nucleotide Polymorphisms in the DCM candidate genes. For each SNP its origin, its primers and the PCR conditions, 
and its informativity are listed.
Gene dbSNP
 access. no. 
ss4985...
SNP Primers (5'-3')
 Forward;
 Reverse
Ta (°C)1 Prod. size (bp) Informativeness2
PIC #chr
ACTC 2973 5,452 G/Aa,3,4 gccctggattttgagaatgagat
acgatcagcaataccagggtaca
62.0 1 1067 0.14 12
CAV1 2978 30,312 A/G b,5 tgagtgccttgcttgtgg
gcatcattggaacttgttgg
62.0 565 0.28 24
2979 30,088 G/A5 tgagtgccttgcttgtgg
gcatcattggaacttgttgg
62.0 565 0.24 24
CSPR3 2980 31,216 A/G 6 ggaggccaggatgagaac
gtttattgtactgaatgatggtcag
62.0 507 0.15 22
2981 25,753 T/C 6 aatcatcctcccattgttcc
cagaagtgctcatagtctttaccc
58.0 510 0.37 24
2982 25,446 A/G 6 aatcatcctcccattgttcc
cagaagtgctcatagtctttaccc
58.0 510 0.24 24
2983 28,779 A/G 6 atggacctttgtatctccag
tctgtaggtttcattcattgg
58.0 455 0.19 24
2984 28,742 C/A 6 atggacctttgtatctccag
tctgtaggtttcattcattgg
58.0 455 0.19 24
2985 28,737 G/A 6 atggacctttgtatctccag
tctgtaggtttcattcattgg
58.0 455 0.19 24
2986 28,642 T/A 6 atggacctttgtatctccag
tctgtaggtttcattcattgg
58.0 455 0.19 24
DES 2989 15,228 C/T 7 cgtcacaacccccacaag
gctgggtgccatgaggtc
67.0 530 0.30 8
2990 15,224 C/G 7 cgtcacaacccccacaag
gctgggtgccatgaggtc
67.0 530 0.19 8
2991 15,166 G/A 7 cgtcacaacccccacaag
gctgggtgccatgaggtc
67.0 530 0.19 8
2992 15,006 C/T 7 cgtcacaacccccacaag
gctgggtgccatgaggtc
67.0 530 0.19 8
2993 19,903 T/C 7 agggcagagggagaccag
gacctaatggtgggctttacc
66.0 575 0.30 8
2975 19,196 C/T c,7,8 ttgcttgaccactaccagga9
agatgttcttagccgcgatg10
57.0 1 402 0.35 12
2976 19,105 G/A 7,8 ttgcttgaccactaccagga9
agatgttcttagccgcgatg10
57.0 1 402 0.30 12
LDB3 2987 14,090 C/T 11 tgttaatcacctctgcggatagt
ggctccctacacgttgatg
58.0 540 0.33 24
2988 25,205 T/C 12,d gcctcctccatcctgacc
cctcccagtaccctgtaggc
66.0 566 0.19 24
s2974 25,452 A/G 12 gcctcctccatcctgacc
cctcccagtaccctgtaggc
66.0 566 0.38 24
PLN 2994 51,818 A/G 13 tggtttgccttcatacactacaac
tgtcttcatctgtgggattttg
64.0 573 0.21 14
SGCD 2995 30,703 G/C 14 ccttcagacccccatctagg
ccacctgacataatcccactttag
66.0 521 0.36 8
2996 151,312 A/G 14 ggaggtagcaaagtatagtgctc
atgttcatgccaacaagc
62.0 558 0.30 8
2997 29,656 C/G 14 ttccagccaactgagaagc
cactgtcatttccatgtcaacc
58.0 525 0.30 8
2998 116,470 A/G 14 gcaatctcctcctccagacc
tcatggcctcactctgatctc
58.0 529 0.38 8
TCAP 2999 28,606 C/T 15,e gctgcttcccttgaatgc
cagacagtggcaggaatcg
64.0 588 0.28 24
2977 29,957 T/C 15,f gtagagggtagcagatttcagg
ctctgggcaaactacaaagc
69.0 555 0.26 16
3000 30,330 A/G 15,g tgctttgtagtttgcccagag
agccagccaccctgtttac
64.0 557 0.30 8BMC Veterinary Research 2007, 3:28 http://www.biomedcentral.com/1746-6148/3/28
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3001 30,687 C/T 15,h tgctttgtagtttgcccagag
agccagccaccctgtttac
64.0 557 0.30 8
TNNT2 3002 10,466 C/T 16 tgaccctcacttggggaac
cgcagggctcttccagac
58.0 519 0.38 24
3003 10,577 T/C 16 tgaccctcacttggggaac
cgcagggctcttccagac
58.0 519 0.38 24
3004 10,671 T/C 16 tgaccctcacttggggaac
cgcagggctcttccagac
58.0 519 0.38 24
VCL 3005 177,743 G/A17 tgcaggccacagagatgc
ggaatgagggcggagcag
62.0 491 0.30 8
1 All PCR program were Touchdown (TD) at the listed Ta, accept for the ACTC SNP: 94°C 5 min, 35× (94°C 30 sec, 62°C 1 min, 72°C 1 min), 72°C 
10 min, 20°C ∞; and for the DES SNPs 19,196 C/T and 19,105 G/A: 94°C 10 min, 35× (94°C 30 sec, 57°C 30 sec, 72°30 sec), 72°C 10 min, 20°∞; 2 
The informativeness of each SNP was described by its polymorphism information content (PIC), based on the number of genotyped chromosomes 
(#chr) listed; 3 SNP detected while sequencing available ACTC SNPs (166C/T and 38C/T of [Genbank: AF203019] and 289T/A of [Genbank: 
AF203020], these were in the dog genome, respectively, 4,871G/A, 5,000 G/A and 5,454 A/T in [Genbank: AAEX01013478)] [26]; 4 in genomic 
contig AAEX01013478; 5 AAEX01048546; 6 AAEX01017412; 7 AAEX01055032; 8 SNP detected while sequencing available DES SNPs (1,808C/T and 
1,851G/C of [Genbank: BK005142], these were in the dog genome, respectively, 19,262 G/A and 19,218C/G in [Genbank: AAEX01055032]) [28]; 9 
M13-tailed F-primer: 5'- GTTTTCCCAGTCACGAC---- 3'; 10 M13-tailed R-primer: 5'- CAGGAAACAGCTATGAC----3'; 11 in genomic contig 
AAEX01016584; 12 AAEX01016582; 13 AAEX01014037; 14 AAEX01016848; 15 AAEX01022011; 16 AAEX01013360; 17 AAEX01016404; a is identical 
to SNP BICF237J37997 (Broad, at [39]); b identical to BICFPJ1220038; c identical to BICFPJ152241; d identical to BICF231J18538; e identical to 
BICFG630J165218; f identical to BIFG630J165217; g identical to BICFG630J165215; h identical to BICFG630J165213.
Table 2: Single Nucleotide Polymorphisms in the DCM candidate genes. For each SNP its origin, its primers and the PCR conditions, 
and its informativity are listed. (Continued)
showed that both homozygous and heterozygous animals
were among the dogs used for WAVE analysis. Conversely,
sometimes WAVE analysis indicated potential presence of
SNPs, yet sequencing of dogs with different WAVE pat-
terns did not confirm these. This could be due to the
sequencing procedure used.
In search of additional SNPs for canine ACTC and DES,
genomic DNA fragments containing SNPs annotated by
others (Table 2) were resequenced. After PCR amplifica-
tion of these fragments, 1 µl of 1:15 diluted PCR product
was used in a Tercycle big dye reaction with the F-PCR-
primer for the ACTC SNP and a HPLC-purified M13 F-
primer (5'-GTTTTCCCAGTCACGAC-3') for the DES
SNPs. The Tercycle consisted of 25 cycles of 30 sec at
96°C, 15 sec at 55°C and 2 min at 60°C. After purifica-
tion (Sephadex TM G50 Superfine, Amersham Bio-
sciences), each product was processed with an ABI PRISM®
3100 Genetic Analyzer (Applied Biosystems). Five SNPs
(ACTC 5,452G/A; DES 19,196C/T and 19,105G/A; LDB3
25,452A/G and TCAP 29.957 T/C) were identified by rese-
quencing areas of earlier described SNPs (Table 2).
Of the total of 33 identified SNPs, 4 were in coding
regions (DES  15,006C/T,  LDB3  14,090C/T,  TCAP
29,957T/C and TNNT2 10,466C/T). These exonic SNPs,
however, did not cause polymorphisms at the amino acid
level. Comparing the 33 newly discovered SNPs to the dog
SNP database of the Broad Institute [39] showed 25 of our
SNPs to be new, the remaining 8 SNPs matched SNPs
present in the Broad database (see Table 2). This indicates
that, in addition to the many SNPs that have become
available by random sequencing of the dog genome,
many more canine SNPs exist. Our limited search for
SNPs in 14 DCM candidate genes took place in a single
breed, the Newfoundland dog. However, a high percent-
age of SNPs found in one breed can be expected to be pol-
ymorphic in other breeds too [40]. All identified SNPs
were submitted to dbSNP and the respective accession
numbers are listed in Table 2.
Detection of microsatellite polymorphisms
Simple DNA sequences composed of CA, GAAA or GA
repeats were identified in the genomic contigs that con-
tain the candidate genes or in neighbouring contigs. For
VCL, a polymorphic microsatellite became available
through personal communication with P.Stabej (Table 3;
a repeat was obtained from BAC RP81-251B5, isolated
using methods as described in [28] with an overgo probe
based on murine VCL exon 17, F-overgo CCAAGGTCA-
GAGAAGCCTTCCAAC, R-overgo AAGTCAGGCTCCT-
GAGGTTGGAAG). Primers were designed from the DNA
sequence flanking the repeats and the forward primer was
fluorescently labelled with 6-FAM or HEX. For some mic-
rosatellites, a 3-primer protocol was used for the PCR
amplification (Table 3), using an M13-tailed (GTTTTC-
CCAGTCACGAC----- (5'-3')) F-primer, a 6-FAM-labelled
M13 primer (GTTTTCCCAGTCACGAC (5'-3')) and a R-
primer. Genotyping PCR reactions were incubated 12 min
at 94°C, followed by 35 cycles of 10 sec at 94°C, 15 sec at
Ta°C and 30 sec at 72°C, and a final step of 20 min at
72°C (Ta in Table 3). An ABI PRISM ® 3100 Genetic Ana-
lyzer (Applied Biosystems) was used for genotyping and
allele sizes were determined with Genescan Analysis 3.7
and Genotyper 3.7 software (Applied Biosystems). Eleven
polymorphic microsatellites were developed for ACTC (2B
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Table 3: Polymorphic microsatellite markers for canine DCM candidate genes1
Gene Repeat Primers (5'-3')
Forward;
  Reverse
Ta (°C) Detected alleles Informativeness2 Origin (bp ... of contig AAEX 010...) Distance to gene3
bp # PIC #chr
ACTC 15CA actccgaagaaggaagtcaac4
gttcccatctatgagggctat
57.0 234–238 2 0.17 10 bp 37,720/..13479 69.2 kb downstr. Stop
20CA ggaacaaggtgctgttagacc5
cacattccaccgagtaggc7
59.0 338–356 5 0.42 24 bp 5,945/..13478 intragenic (intron 4)
CAV1 13CA ccacagagctagaaagctacg4
tgttgcaaacaccctatgat
54.5 240–242 2 0.28 24 bp 39,315/...48546 8.2 kb downstr. Stop
CSRP3 15CA catgtcctgcaagttaatggt4
ggatttctattctgggtttcc
53.0 237–245 3 0.41 24 bp 38,367/..17412 2.8 kb upstr. Start
LMNA 16CA gggtggtagatgagcatttc6
gaagagaacaagtgggcaag
54.5 204–212 4 0.36 12 bp 5,128/..12734 9.3 kb downstr. Stop
18GAAA ggaagatgagactgttagaatgc5
caggccatgattacttttcc7
57.0 321–344 6 0.67 24 bp 26,754/..12735 22.6 kb downstr. Stop
MYH7 21CA gatatcctgggattaaagactgg5
ctattttgccctcttcatgg7
58.0 351–363 4 0.37 24 bp 1,418/..41098 36.6 kb downstr. Stop
TNNI3 20CAa tcaaacagggaaacctgaac6
gattattcagctcccagaacc7
57.0 297–301 3 0.38 24 bp 597/..53929 119.3 kb upstr. Start
20CAb ttccagttgattgtttctctgc5 gcggtttagcactgcattc7 59.0 302–306 2 0.08 24 bp 13,248/..53916 110.2 kb downstr. Stop
17GA tccaacctcagggtactgg5 catgccatggagctatgc7 59.0 304–312 3 0.37 24 bp 48,910/..53930 179.8 kb upstr. Start
TPM1 19CA8 actgtgtccagagtgcagcta4
gattgctagactggc
60.0 467–483 4 0.67 12 bp 88,113/..08742 6.5 kb downstr. Stop
VCL 15GAAA9 caatttcttttccaatcacattag 10
gccattttgcattctcttcaa
54.0 150–170 6 0.69 24 bp 12,680/..16406 88.6 kb downstr. Stop
1 Microsatellites for DES and SGCD were demonstrated in, respectively, [28] and [30]; 2 The informativeness of each SNP was described by its polymorphism information content (PIC), based on the 
number of genotyped chromosomes (#chr) listed; 3 Based on genomic build 1.1; 4 F-primer fluorescently labelled with 6FAM; 5 Three-primer protocol used; 6 F-primer fluorescently labelled with 
HEX; 7 extra tail on R-primer: GTGTCTT---- (5'-3') to promote addition of an Adenosine residue at the 3'-end of the complementary DNA strand; 8 Microsatellite demonstrated in [31]; 9 Personal 
communication P.Stabej; 10 F-primer fluorescently labelled with TET.BMC Veterinary Research 2007, 3:28 http://www.biomedcentral.com/1746-6148/3/28
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markers), CAV1 (1), CSRP3 (1), LMNA (2), MYH7 (1),
TNNI3 (3) and VCL (1) (Table 3). The markers, mostly
CA-repeats, showed multiple allele sizes (2–6 alleles/
marker) in a group of 16 Newfoundland dogs (Table 3).
To describe the informativeness of our microsatellite
markers, the polymorphism information content (PIC)
was obtained based on the genotypes of unrelated found-
ers of a family of Newfoundland dogs (Table 3). Accord-
ing to [41], 2 of the 11 newly designed microsatellites
were considered highly informative (PIC>0.50), 7 reason-
able informative (0.25<PIC<0.50) and 2 slightly informa-
tive (PIC<0.25) in the Newfoundland founder dogs.
Besides the 11 polymorphic microsatellites, 2 other mark-
ers were found to be monomorphic in the group of New-
foundland dogs, but might be polymorphic in other
breeds. This was a MYH7 CA-repeat (position 11,730 of
[Genbank: AAEX010141100]) and a TNNI3  CA-repeat
(position 17,739 of [Genbank: AAEX01053915]. An
already available microsatellite for TPM1 [31] was shown
to be highly informative in our group (Table 3).
The distance between the microsatellite and the corre-
sponding gene was derived from the dog genome build
1.1 [42] and can be found in Table 3. This distance varied
from zero for an intragenic microsatellite to 179.8 kb. The
genomic locations of polymorphic microsatellites,
already available for DES, SGCD, TPM1 and VCL, were
determined. For DES a CA-repeat [28] was located at posi-
tion 5,688 of [Genbank: AAEX01055032], 9.0 kb down-
stream of the stop codon. For SGCD both a GAAA-repeat
and a CA-repeat were available [30]. The first was located
at position 76,364 of [Genbank: AAEX4801016848], the
second at position 42,047 of the same genomic contig
and both markers are in intron 7 of SGCD. For TPM1 a
GA-repeat [31] was located at position 88,113 of [Gen-
bank: AAEX01008742], 6.5 kb downstream of the stop
codon. A polymorphic GAAA-repeat for VCL showed to be
located at position 12,680 of [Genbank: AAEX01016406]
in the dog genome, 88.6 kb downstream of the stop
codon.
Conclusion
With the annotation of these 14 candidate genes for DCM
and the identification of polymorphic markers, the genes
can be evaluated for the involvement in breed specific
DCM. The SNPs and microsatellites presented in this
paper are a powerful tool to analyse linkage between the
fourteen candidate genes encoding cytoskeletal proteins
and DCM in the dog. The annotation of each gene facili-
tates screening of these genes for mutations in naturally
occurring canine DCM in specific breeds, potential mod-
els for forms of human DCM.
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